Order Article Reprints

Su F, Wu Y, Li J, Huang Y, Yu B, Xu L, Xue Y, Xiao C, Yuan X. Escherichia coli Heat-Labile Enterotoxin B Subunit Combined with Ginsenoside Rg1 as an Intranasal Adjuvant Triggers Type I Interferon Signaling Pathway and Enhances Adaptive Immune Responses to an Inactivated PRRSV Vaccine in ICR Mice. Vaccines. 2021; 9(3):266. https://doi.org/10.3390/vaccines9030266

Su, Fei, Yige Wu, Junxing Li, Yee Huang, Bin Yu, Lihua Xu, Yin Xue, Chenwen Xiao, and Xiufang Yuan. 2021. "Escherichia coli Heat-Labile Enterotoxin B Subunit Combined with Ginsenoside Rg1 as an Intranasal Adjuvant Triggers Type I Interferon Signaling Pathway and Enhances Adaptive Immune Responses to an Inactivated PRRSV Vaccine in ICR Mice" Vaccines 9, no. 3: 266. https://doi.org/10.3390/vaccines9030266

Su, F., Wu, Y., Li, J., Huang, Y., Yu, B., Xu, L., Xue, Y., Xiao, C., & Yuan, X. (2021). Escherichia coli Heat-Labile Enterotoxin B Subunit Combined with Ginsenoside Rg1 as an Intranasal Adjuvant Triggers Type I Interferon Signaling Pathway and Enhances Adaptive Immune Responses to an Inactivated PRRSV Vaccine in ICR Mice. Vaccines, 9(3), 266. https://doi.org/10.3390/vaccines9030266